Table 1.
Age, concomitant diseases, and viral status of the SYNERGY male and female patients at baseline
| Males (N=121) | Females (N=104) | P-value | |
|---|---|---|---|
| Age, mean (SD) | 48.9 (12.8) | 50.8 (12.5) | 0.2499 |
| Concomitant diseases (%) | 45.5 | 48.1 | 0.6942 |
| Cardiovascular diseases | 24.8 | 30.8 | |
| Type 1 diabetes | 3.3 | 0 | |
| Type 2 diabetes | 7.4 | 3.8 | |
| Cerebrovascular diseases | 0 | 1 | |
| Renal diseases | 2.5 | 1.9 | |
| Other diseases | 21.5 | 21.2 | |
| Viral positivity (%) | 53.7 | 68.3 | 0.0105 |
| HBV | 5 | 3.8 | |
| HCV | 5.8 | 3.8 | |
| Cytomegalovirus | 36.4 | 46.2 | |
| HIV 1–2 | 0 | 0 | |
| HSV 1 | 42.1 | 53.8 | |
| HSV 2 | 31.4 | 37.5 | |
| Varicella-zoster virus | 17.4 | 19.2 | |
| Epstein–Barr virus | 32.2 | 42.3 |
Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; SD, standard deviation; SYNERGY, Observational Study of infectious events in psoriasis complicated by active psoriatic arthritis.